NOVEL CANCER ANTIGENS AND ANTIBODIES OF SAID ANTIGENS

In a non-limiting aspect, provided is an isolated antibody that binds to any of the following proteins: XPR1, NOX1, MARVELD3 isoform 1, MARVELD3 isoform 2, SPINT2, MANSC1, SLC12A2, CDCP1, SEZ6L2, FLVCR1, SLC7A5, STEAP1, MMP14, TNFRSF21, and TMPRSS4. 在一种非限定性的实施方式中提供了分离的抗体，所述分离的抗体与XPR1，NOX1，MARVELD3同工...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	KATO KUNIYASU, NEZU JUNICHI, HOSHINO MAYUMI, NAGANO KOHJI, YOKOTA YUKARI, KIMURA NAOKI, KODAMA TATSUSHI
Format:	Patent
Sprache:	chi ; eng
Schlagworte:	BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS THEREOF CULTURE MEDIA ENZYMOLOGY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS SPIRITS VINEGAR WINE
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	In a non-limiting aspect, provided is an isolated antibody that binds to any of the following proteins: XPR1, NOX1, MARVELD3 isoform 1, MARVELD3 isoform 2, SPINT2, MANSC1, SLC12A2, CDCP1, SEZ6L2, FLVCR1, SLC7A5, STEAP1, MMP14, TNFRSF21, and TMPRSS4. 在一种非限定性的实施方式中提供了分离的抗体，所述分离的抗体与XPR1，NOX1，MARVELD3同工型1，MARVELD3同工型2，SPINT2，MANSC1，SLC12A2，CDCP1，SEZ6L2，FLVCR1，SLC7A5，STEAP1，MMP14，TNFRSF21，TMPRSS4中任一种蛋白质结合。